Sheel Biotech Defers FY26 Dividend, Proposes Sale Of Company Land

Board approved the 35th AGM for 24 September 2026 and recommended shareholder approval for sale, transfer or disposal of specified company land/immovable property. Dividend for FY26 was deferred to retain funds for profitability, growth and business requirements. The land disposal is a material asset-monetization decision requiring a special resolution, while dividend retention indicates priority for internal funding and business needs. Sale consideration, counterparty, timing and intended use of proceeds were not disclosed. Related-party transactions for FY26 were placed for ratification, with no financial results or operating details included in the filing.